Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC
The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…
GW Pharma CEO on new cannabis-derived drug
GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says about the future of cannabis-derived drugs.
Firing up the cannabis trade
Trader Tim Seymour on why he’s long a number of cannabis stocks. With CNBC’s Courtney Reagan and the Fast Money traders, Victoria Fernandez and Delano Saporu. For access to live…
Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC
He’s spent time in the C-Suite at Victoria’s Secret and DSW, and now, he’s turning his attention to cannabis. Jim Cramer finds out what retailers can bring to the table…
Expect exponential growth in global cannabis sales: Arcview founder
Troy Dayton of Arcview joins CNBC’s “Power Lunch” team to talk about cannabis stocks and what investors should know. Aurora Cannabis said Chief Executive Terry Booth will retire and Executive…
Cannabis stocks may be relighting in 2020
CNBC’s Frank Holland reports on the cannabis comeback. With CNBC’s Brian Sullivan and the Fast Money traders, Tim Seymour, Brian Kelly, Karen Finerman and Guy Adami. “I think this is…
Aurora Cannabis’ Michael Singer on earnings and vaping
Aurora Cannabis executive chairman Michael Singer joins “Squawk on the Street” to discuss the company’s earnings as well as potential vaping bans.
Here are the challenges the cannabis industry faces in accessing the US banking system
The Senate Banking Committee will hold its first hearing on the challenges facing cannabis and banking. Jaret Seiberg, managing director at Cowen, joins “Squawk Box” to discuss.
Cronos CEO on nicotine vaping versus cannabis vaping
Cronos CEO Mike Gorenstein tells Jim Cramer what his company is doing different to enter the cannabis vaping space, particularly in the Canadian market.
There’s ‘exuberance’ in markets, driving cannabis stock higher: Canaccord Genuity analyst
Matt Bottomley from Canaccord Genuity says there’s a lot of exuberance coming into the market that may be moving the cannabis stock higher. He joins ‘Closing Bell’ to discuss his…